← Back to Search

Intermittent Hypoxia for Balance Control

N/A
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session
Awards & highlights

Study Summary

This trialwill study the effects of hypoxia on ankle muscle activation during walking & balance in younger & older adults. Participants will switch between hypoxia & sham, and muscle activation levels will be measured. It is hypothesized that hypoxia will increase muscle activation in both groups.

Eligible Conditions
  • Intermittent Hypoxia
  • Normoxia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ankle
Soleus muscle structure

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intermittent HypoxiaExperimental Treatment1 Intervention
Participants will receive intermittent hypoxia and perform balance and gait assessments before and after the intermittent hypoxia session.
Group II: Normoxia (sham)Placebo Group1 Intervention
Participants will receive normoxia and perform balance and gait assessments before and after the normoxia session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intermittent Hypoxia
2017
N/A
~50

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
356 Previous Clinical Trials
81,476 Total Patients Enrolled
2 Trials studying Intermittent Hypoxia
95 Patients Enrolled for Intermittent Hypoxia

Media Library

Intermittent Hypoxia Clinical Trial Eligibility Overview. Trial Name: NCT05463042 — N/A
Intermittent Hypoxia Research Study Groups: Intermittent Hypoxia, Normoxia (sham)
Intermittent Hypoxia Clinical Trial 2023: Intermittent Hypoxia Highlights & Side Effects. Trial Name: NCT05463042 — N/A
Intermittent Hypoxia 2023 Treatment Timeline for Medical Study. Trial Name: NCT05463042 — N/A
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top